PetMed ExpressPETS 56 Forward PE Ratio is 28.00 as of Jul. 10, 2026. GuruFocus rates PETS with a GF Score™ of 56/100 and a GF Value™ of $2.88 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 314 Healthcare Providers & Services companies, PetMed Express ranks worse than 70.06% on this metric.
PetMed Express (NAS:PETS) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
PetMed Express Forward PE Ratio Related Terms
PetMed Express Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for PetMed Express's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetMed Express Forward PE Ratio Chart
PetMed Express Annual Data
Trend
2016-03
2017-03
2018-03
2019-03
2020-03
2021-03
2026-03
Forward PE Ratio
17.27
19.01
21.60
10.64
20.92
19.76
225.00
PetMed Express Quarterly Data
2015-12
2016-03
2016-06
2016-09
2016-12
2017-03
2017-06
2017-09
2017-12
2018-03
2018-06
2018-09
2018-12
2019-03
2019-06
2019-09
2019-12
2020-03
2020-06
2020-09
2020-12
2021-03
2021-06
2021-09
2021-12
2025-12
2026-03
Forward PE Ratio
17.15
17.27
18.08
19.88
21.19
19.01
34.72
28.33
27.55
21.60
19.88
14.90
10.55
10.64
8.24
14.27
20.12
20.92
26.25
21.37
18.98
19.76
23.58
20.00
17.86
347.00
225.00
PETS vs SHFH, BHIC, SCNX: Forward PE Ratio Comparison
For the Pharmaceutical Retailers subindustry, PetMed Express's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetMed Express Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where PetMed Express's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
PetMed Express (PETS) has a Forward PE Ratio of 28.00 as of Jul. 10, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on PetMed Express and its competitors. According to the industry distribution chart, PetMed Express ranks #220 out of 314 companies in the Healthcare Providers & Services industry, placing it in the top 70.1%.
Is PetMed Express' Forward PE Ratio too high?
PetMed Express' current Forward PE Ratio is 28.00. The Healthcare Providers & Services industry median Forward PE Ratio is 18.32. PetMed Express' value of 28.00 is 52.8% above this industry median. Based on the distribution chart, PetMed Express ranks #220 out of 314 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PetMed Express has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PetMed Express' Forward PE Ratio compare to SHFH and BHIC?
According to the Healthcare Providers & Services industry distribution chart, PetMed Express ranks #220 out of 314 companies for Forward PE Ratio. This places PetMed Express in the lower half of its industry. The industry median Forward PE Ratio is 18.32. PetMed Express' value of 28.00 is 52.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.32, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PetMed Express's current Forward PE Ratio of 28.00 is 52.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on PetMed Express and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetMed Express's current Forward PE Ratio is 28.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetMed Express stock overvalued right now?
Based on GuruFocus' analysis, PetMed Express (PETS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.88, compared to a current price of $1.97 — trading 31.8% below its estimated fair value. The current Forward PE Ratio is 28.00 and 52.8% above the Healthcare Providers & Services industry median of 18.32. PetMed Express' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For PetMed Express (PETS), the current Forward PE Ratio is 28.00 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetMed Express (PETS) Overvalued in 2026?
Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued.
The current stock price of $1.97 is trading 31.8% below its estimated GF Value™ of $2.88.
GuruFocus considers PetMed Express to be Possible Value Trap.
Key valuation signals for PETS:
Forward PE Ratio: 28.00
GF Value™: $2.88 vs. price of $1.97 (31.8% below fair value)
Industry Position: 52.8% above the Healthcare Providers & Services median (#220 of 314)
No single metric tells the full story. See the PETS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
56GF Score
Get the complete analysis for PETS
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETS has been successfully added to your 